本文通过对国内外医药生物技术产业现状的分析，详细阐述了中国生物制药企业目前所面临的机遇和挑战。
The paper analyzed the present developments in medical biotechnology industries home and abroad, and discussed the opportunities and challenges facing biopharmaceutical companies in China.
根据合作协议，应求苏州和凯杰苏州将共同加快生物标志物的发现及应用转化，从而更好的为中国生物制药市场提供服务。
Pursuant to the agreement, InvitroCue Suzhou and QIAGEN Suzhou will jointly accelerate the discovery of biomarkers and translational medicine research for the Chinese biopharmaceutical market.
根据合作协议，应求苏州和凯杰苏州将共同加快生物标志物的发现及应用转化，从而更好的为中国生物制药市场提供服务。
Pursuant to the agreement, InvitroCue Suzhou and QIAGEN Suzhou will jointly accelerate the discovery of biomarkers and translational medicine research for the Chinese biopharmaceutical market.
应用推荐